Alpha-thalassemia is a form of thalassemia. With our company's profound expertise in A-THAL research, we are well-equipped to offer tailored solutions and comprehensive support to facilitate your research process from A-THAL therapy development to therapy commercialization.

At our company, we cater to a global audience of professionals engaged in rare disease drug development and research. Our mission is to support researchers worldwide by offering a comprehensive range of products and preclinical drug development services. Beyond a focus on gene therapy, our diverse portfolio equips researchers with the tools and support needed for every stage of drug development.